Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers

Plain-language guide to PMID 21341925 (2011): double-blind randomized controlled trial study of Therapeutic nicotine (patch, non-peptide) in 54 women.

Key Facts

PMID: 21341925
Journal: Experimental and clinical psychopharmacology
Year: 2011
Study type: Randomized Controlled Trial
Authors: Kleykamp BA et al. (3 authors)
DOI: 10.1037/a0022417

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial paper looks at Therapeutic nicotine (patch, non-peptide).

The purpose of this double-blind, randomized, laboratory study was to use process-specific cognitive tasks to examine the effects of TN and tobacco smoking on attention and working memory in overnight-abstinent smokers (N = 124; 54 women).

Why It Was Studied

Smokers experience cognitive decrements during tobacco abstinence and boosts in performance on resumption of smoking.

Few studies have examined whether smoking cessation treatments such as transdermal nicotine (TN) ameliorate these decrements or attenuate the cognitive effects of smoking.

Who Took Part

The abstract describes 54 women taking part.

PubMed indexes the participants as young adults, adults and middle-aged adults, both men and women.

How the Study Was Run

The researchers set it up as a randomized and double-blind study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Neither the women nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

What Was Measured

Outcome measures were administered before and after smoking and included tasks measuring attention (alerting, orienting, and executive function), working memory (verbal and spatial), and psychomotor function.

Topics PubMed links to this paper include Administration, Cutaneous, Attention, Memory, Short-Term, Nicotine, Psychomotor Performance, Smoking and Smoking Cessation.

What This Means in Plain Language

The paper is a randomized and double-blind study of Therapeutic nicotine (patch, non-peptide) in 54 women.

The publication is from 2011 (Experimental and clinical psychopharmacology), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Therapeutic nicotine (patch, non-peptide) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.